Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05039_nanopub.RANHdFSuBw8PnzCle6IZ9G1SyIM9zX7FPGN7k8zXFDc2c#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB05039 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05039 label "Indacaterol [drugbank:DB05039]" assertion.
- drugbank:DB05039 seeAlso arcapta-neohaler-drug.htm assertion.
- drugbank:DB05039 seeAlso indacaterol.html assertion.
- drugbank:DB05039 seeAlso DB05039 assertion.
- drugbank:DB05039 description "Indacaterol is a novel, ultra-long-acting, rapid onset β(2)-adrenoceptor agonist developed for Novartis for the once-daily management of asthma and chronic obstructive pulmonary disease. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. Indacaterol is provided as its maleate salt form. Indacaterol is also a chiral molecule but only the pure R-enantiomer is dispensed." assertion.
- drugbank:DB05039 identifier "drugbank:DB05039" assertion.
- drugbank:DB05039 title "Indacaterol" assertion.
- drugbank:DB05039 drugbank_vocabulary:x-cas cas:312753-06-3 assertion.
- drugbank:DB05039 drugbank_vocabulary:drugbank-id "DB05039" assertion.
- drugbank:DB05039 bio2rdf_vocabulary:x-identifiers.org DB05039 assertion.
- drugbank:DB05039 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05039" assertion.
- drugbank:DB05039 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05039 bio2rdf_vocabulary:identifier "DB05039" assertion.
- drugbank:DB05039 drugbank_vocabulary:x-wikipedia wikipedia:Indacaterol assertion.
- drugbank:DB05039 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165958348 assertion.
- drugbank:DB05039 drugbank_vocabulary:x-kegg kegg:D09318 assertion.
- drugbank:DB05039 drugbank_vocabulary:x-chebi chebi:68575 assertion.
- drugbank:DB05039 drugbank_vocabulary:x-atc atc:R03AC18 assertion.
- drugbank:DB05039 drugbank_vocabulary:x-ahfs ahfs:12:12.08.12 assertion.
- drugbank:DB05039 drugbank_vocabulary:x-ndc ndc:0078-0619-15 assertion.